{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:27:39Z","timestamp":1768033659175,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00750-w","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:38:11Z","timestamp":1768019891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultrasonication-assisted green synthesis, in silico EGFR-binding analysis, and cytotoxic evaluation of nitro-perimidines for non-small cell lung cancer"],"prefix":"10.1007","volume":"40","author":[{"given":"Meera","family":"Gopinadh","sequence":"first","affiliation":[]},{"given":"A. P.","family":"Sreehari","sequence":"additional","affiliation":[]},{"given":"K. S.","family":"Sunish","sequence":"additional","affiliation":[]},{"given":"Sobhi","family":"Daniel","sequence":"additional","affiliation":[]},{"given":"M. Muhammed","family":"Shafeer","sequence":"additional","affiliation":[]},{"given":"G.","family":"Deepa","sequence":"additional","affiliation":[]},{"given":"T. P.","family":"Sajeevan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"750_CR1","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","volume":"7","author":"AK Ganti","year":"2021","unstructured":"Ganti AK, Klein AB, Cotarla I et al (2021) Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol 7:1824. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4932","journal-title":"JAMA Oncol"},{"key":"750_CR2","doi-asserted-by":"publisher","DOI":"10.2196\/43651","volume":"9","author":"G Luo","year":"2023","unstructured":"Luo G, Zhang Y, Etxeberria J et al (2023) Projections of lung cancer incidence by 2035 in 40 countries worldwide: population-based study. JMIR Public Health Surveill 9:e43651. https:\/\/doi.org\/10.2196\/43651","journal-title":"JMIR Public Health Surveill"},{"key":"750_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"750_CR4","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1158\/2159-8290.CD-14-0337","volume":"4","author":"DAE Cross","year":"2014","unstructured":"Cross DAE, Ashton SE, Ghiorghiu S et al (2014) AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov 4:1046\u20131061. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0337","journal-title":"Cancer Discov"},{"key":"750_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund S, Avanzato D, Lanzetti L (2018) Emerging functions of the EGFR in cancer. Mol Oncol 12:3\u201320","journal-title":"Mol Oncol"},{"key":"750_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1517\/14728222.2011.648617","volume":"16","author":"P Seshacharyulu","year":"2012","unstructured":"Seshacharyulu P, Ponnusamy MP, Haridas D et al (2012) Targeting the EGFR signaling pathway in cancer therapy. Expert Opin Ther Targets 16:15\u201331","journal-title":"Expert Opin Ther Targets"},{"key":"750_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok TS, Wu Y-L, Thongprasert S et al (2009) Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 361:947\u2013957. https:\/\/doi.org\/10.1056\/NEJMoa0810699","journal-title":"N Engl J Med"},{"key":"750_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"J-C Soria","year":"2018","unstructured":"Soria J-C, Ohe Y, Vansteenkiste J et al (2018) Osimertinib in untreated EGFR -mutated advanced non\u2013small-cell lung cancer. N Engl J Med 378:113\u2013125. https:\/\/doi.org\/10.1056\/NEJMoa1713137","journal-title":"N Engl J Med"},{"key":"750_CR9","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R et al (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non\u2013small-cell lung cancer to gefitinib. N Engl J Med 350:2129\u20132139. https:\/\/doi.org\/10.1056\/NEJMoa040938","journal-title":"N Engl J Med"},{"key":"750_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nm.3854","volume":"21","author":"KS Thress","year":"2015","unstructured":"Thress KS, Paweletz CP, Felip E et al (2015) Acquired EGFR C797S mutation mediates resistance to AZD9291 in non\u2013small cell lung cancer harboring EGFR T790M. Nat Med 21:560\u2013562. https:\/\/doi.org\/10.1038\/nm.3854","journal-title":"Nat Med"},{"key":"750_CR11","first-page":"411","volume":"4","author":"Y Lin","year":"2014","unstructured":"Lin Y, Wang X, Jin H (2014) EGFR-TKI resistance in NSCLC patients: mechanisms and strategies. Am J Cancer Res 4:411\u2013435","journal-title":"Am J Cancer Res"},{"key":"750_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xinn.2021.100103","volume":"2","author":"X Du","year":"2021","unstructured":"Du X, Yang B, An Q et al (2021) Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. The Innovation 2:100103. https:\/\/doi.org\/10.1016\/j.xinn.2021.100103","journal-title":"The Innovation"},{"key":"750_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nrc2559","volume":"9","author":"J Zhang","year":"2009","unstructured":"Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9:28\u201339. https:\/\/doi.org\/10.1038\/nrc2559","journal-title":"Nat Rev Cancer"},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00044-020-02656-8","volume":"30","author":"KRA Abdellatif","year":"2021","unstructured":"Abdellatif KRA, Bakr RB (2021) Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment. Med Chem Res 30:31\u201349","journal-title":"Med Chem Res"},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.55544\/jrasb.3.5.19","volume":"3","author":"PP Sarwade","year":"2024","unstructured":"Sarwade PP, Srinandhinidevi KM, Dangwal K et al (2024) Role of pyrimidine derivatives in the treatment of cancer. J Res Appl Sci Biotechnol 3:181\u2013193. https:\/\/doi.org\/10.55544\/jrasb.3.5.19","journal-title":"J Res Appl Sci Biotechnol"},{"key":"750_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.861288","author":"TT Yadav","year":"2022","unstructured":"Yadav TT, Moin Shaikh G, Kumar MS et al (2022) A review on fused pyrimidine systems as EGFR inhibitors and their structure\u2013activity relationship. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2022.861288","journal-title":"Front Chem"},{"key":"750_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/cbdd.14124","volume":"100","author":"A Kizhakkedath Ratheesh","year":"2022","unstructured":"Kizhakkedath Ratheesh A, Pottankottu Jayan A, Presanna AT, Nirmala SV (2022) Pyrimidine derivatives as EGFR tyrosine kinase inhibitors in non-small-cell lung cancer: a comprehensive review. Chem Biol Drug Des 100:599\u2013621. https:\/\/doi.org\/10.1111\/cbdd.14124","journal-title":"Chem Biol Drug Des"},{"key":"750_CR18","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1080\/07391102.2023.2252082","volume":"42","author":"R Pal","year":"2024","unstructured":"Pal R, Teli G, Sengupta S et al (2024) An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC). J Biomol Struct Dyn 42:9795\u20139811. https:\/\/doi.org\/10.1080\/07391102.2023.2252082","journal-title":"J Biomol Struct Dyn"},{"key":"750_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/1871520620666200721102726","volume":"21","author":"GSP Matada","year":"2020","unstructured":"Matada GSP, Abbas N, Dhiwar PS et al (2020) Design, synthesis, in silico and in vitro evaluation of novel pyrimidine derivatives as EGFR inhibitors. Anticancer Agents Med Chem 21:451\u2013461. https:\/\/doi.org\/10.2174\/1871520620666200721102726","journal-title":"Anticancer Agents Med Chem"},{"key":"750_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105078","author":"IMM Othman","year":"2021","unstructured":"Othman IMM, Alamshany ZM, Tashkandi NY et al (2021) New pyrimidine and pyrazole-based compounds as potential EGFR inhibitors: synthesis, anticancer, antimicrobial evaluation and computational studies. Bioorg Chem. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105078","journal-title":"Bioorg Chem"},{"key":"750_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1335373","author":"R Motta-Guerrero","year":"2024","unstructured":"Motta-Guerrero R, Leon Garrido-Lecca A, Failoc-Rojas VE et al (2024) Effectiveness and safety of the bevacizumab and erlotinib combination versus erlotinib alone in EGFR mutant metastatic non-small-cell lung cancer: systematic review and meta-analysis. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1335373","journal-title":"Front Oncol"},{"key":"750_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/BJ20121513","volume":"448","author":"JH Park","year":"2012","unstructured":"Park JH, Liu Y, Lemmon MA, Radhakrishnan R (2012) Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Biochem J 448:417\u2013423. https:\/\/doi.org\/10.1042\/BJ20121513","journal-title":"Biochem J"},{"issue":"5","key":"750_CR23","doi-asserted-by":"publisher","first-page":"1800387","DOI":"10.1002\/ardp.201800387","volume":"352","author":"AGA El-Helby","year":"2019","unstructured":"El-Helby AGA, Ayyad RRA, Zayed MF et al (2019) Design, synthesis, in silico ADMET profile and GABA-A docking of novel phthalazines as potent anticonvulsants. Arch Pharm (Weinheim) 352(5):1800387. https:\/\/doi.org\/10.1002\/ardp.201800387","journal-title":"Arch Pharm (Weinheim)"},{"key":"750_CR24","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s11164-011-0482-9","volume":"38","author":"FA Bassyouni","year":"2012","unstructured":"Bassyouni FA, Abu-Bakr SM, Hegab KH et al (2012) Synthesis of new transition metal complexes of 1H-perimidine derivatives having antimicrobial and anti-inflammatory activities. Res Chem Intermed 38:1527\u20131550. https:\/\/doi.org\/10.1007\/s11164-011-0482-9","journal-title":"Res Chem Intermed"},{"key":"750_CR25","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/10406638.2021.2019803","volume":"43","author":"J Soni","year":"2023","unstructured":"Soni J, Sethiya A, Sahiba N et al (2023) Graphene oxide as metal-free catalyst in the two-component reaction to generate some novel perimidines and antimicrobial evaluation. Polycycl Aromat Compd 43:674\u2013685. https:\/\/doi.org\/10.1080\/10406638.2021.2019803","journal-title":"Polycycl Aromat Compd"},{"key":"750_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.132056","volume":"1252","author":"CA Fern\u00e1ndez-Gij\u00f3n","year":"2022","unstructured":"Fern\u00e1ndez-Gij\u00f3n CA, Olvera-Mancilla J, Le LR et al (2022) 2-Substituted perimidines: Zwitterionic tauterism in solid state, substituent effect on their crystal packing and biological activity. J Mol Struct 1252:132056. https:\/\/doi.org\/10.1016\/j.molstruc.2021.132056","journal-title":"J Mol Struct"},{"key":"750_CR27","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1007\/s11164-013-1501-9","volume":"41","author":"TA Farghaly","year":"2015","unstructured":"Farghaly TA, Abdallah MA, Muhammad ZA (2015) New 2-heterocyclic perimidines: synthesis and antimicrobial activity. Res Chem Intermed 41:3937\u20133947. https:\/\/doi.org\/10.1007\/s11164-013-1501-9","journal-title":"Res Chem Intermed"},{"key":"750_CR28","doi-asserted-by":"crossref","unstructured":"Arya K, Dandia A (2007) Regioselective Synthesis of Biologically Important Scaffold Spiro [Indole-Perimidines]: An Antitumor Agents","DOI":"10.1002\/chin.200803162"},{"key":"750_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/ardp.201200486","volume":"346","author":"TA Farghaly","year":"2013","unstructured":"Farghaly TA, Mahmoud HK (2013) Synthesis, tautomeric structures, and antitumor activity of new perimidines. Arch Pharm (Weinheim) 346:392\u2013402. https:\/\/doi.org\/10.1002\/ardp.201200486","journal-title":"Arch Pharm (Weinheim)"},{"key":"750_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11030-017-9790-3","volume":"22","author":"A Kumar","year":"2018","unstructured":"Kumar A, Banerjee S, Roy P et al (2018) Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives. Mol Divers 22:113\u2013127. https:\/\/doi.org\/10.1007\/s11030-017-9790-3","journal-title":"Mol Divers"},{"key":"750_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1021\/jm00053a005","volume":"36","author":"B Stefanska","year":"1993","unstructured":"Stefanska B, Dzieduszycka M, Martelli S et al (1993) 6-[(Aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation. J Med Chem 36:38\u201341. https:\/\/doi.org\/10.1021\/jm00053a005","journal-title":"J Med Chem"},{"key":"750_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0968-0896(01)00358-3","volume":"10","author":"M Dzieduszycka","year":"2002","unstructured":"Dzieduszycka M, Martelli S, Arciemiuk M et al (2002) Effect of modification of 6-[(Aminoalkyl)amino]-7H-benzo[e]-perimidin-7-ones on their cytotoxic activity toward sensitive and multidrug resistant tumor cell lines. Synthesis and biological evaluation. Bioorg Med Chem 10:1025\u20131035. https:\/\/doi.org\/10.1016\/S0968-0896(01)00358-3","journal-title":"Bioorg Med Chem"},{"key":"750_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s41061-020-00307-5","volume":"378","author":"N Sahiba","year":"2020","unstructured":"Sahiba N, Agarwal S (2020) Recent advances in the synthesis of perimidines and their applications. Top Curr Chem 378:44. https:\/\/doi.org\/10.1007\/s41061-020-00307-5","journal-title":"Top Curr Chem"},{"key":"750_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103012","volume":"89","author":"M Munier","year":"2019","unstructured":"Munier M, Tritsch D, Li\u00e8vremont D et al (2019) Synthesis and biological evaluation of aryl phosphoramidate prodrugs of fosfoxacin and its derivatives. Bioorg Chem 89:103012. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103012","journal-title":"Bioorg Chem"},{"key":"750_CR35","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1126\/science.247.4949.1439","volume":"247","author":"KS Suslick","year":"1990","unstructured":"Suslick KS (1990) Sonochemistry. Science 247:1439\u20131445. https:\/\/doi.org\/10.1126\/science.247.4949.1439","journal-title":"Science"},{"key":"750_CR36","doi-asserted-by":"publisher","DOI":"10.1063\/5.0213317","author":"Y Cao","year":"2024","unstructured":"Cao Y, Balduf T, Beachy MD et al (2024) Quantum chemical package Jaguar: a survey of recent developments and unique features. J Chem Phys. https:\/\/doi.org\/10.1063\/5.0213317","journal-title":"J Chem Phys"},{"key":"750_CR37","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","volume":"113","author":"AD Bochevarov","year":"2013","unstructured":"Bochevarov AD, Harder E, Hughes TF et al (2013) Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences. Int J Quantum Chem 113:2110\u20132142. https:\/\/doi.org\/10.1002\/qua.24481","journal-title":"Int J Quantum Chem"},{"key":"750_CR38","unstructured":"Schr\u00f6dinger LLC (2025) Schr\u00f6dinger Release 2025\u20134: Jaguar"},{"key":"750_CR39","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","volume":"35","author":"M Wiederstein","year":"2007","unstructured":"Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:W407\u2013W410. https:\/\/doi.org\/10.1093\/nar\/gkm290","journal-title":"Nucleic Acids Res"},{"key":"750_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283\u2013291. https:\/\/doi.org\/10.1107\/S0021889892009944","journal-title":"J Appl Crystallogr"},{"key":"750_CR41","unstructured":"Schr\u00f6dinger Release 2025\u20134: Glide (2025) Schr\u00f6dinger Release 2025\u20134: Glide"},{"key":"750_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","volume":"69","author":"T Halgren","year":"2007","unstructured":"Halgren T (2007) New method for fast and accurate binding-site identification and analysis. Chem Biol Drug Des 69:146\u2013148. https:\/\/doi.org\/10.1111\/j.1747-0285.2007.00483.x","journal-title":"Chem Biol Drug Des"},{"key":"750_CR43","unstructured":"Schr\u00f6dinger LLC (2025) Schr\u00f6dinger Release 2025\u20133: SiteMap, Version 2025\u20133"},{"key":"750_CR44","unstructured":"Schr\u00f6dinger LLC (2025) Maestro User Manual, Version 2025\u20133"},{"key":"750_CR45","unstructured":"Schr\u00f6dinger LLC (2025) Schr\u00f6dinger Release 2025\u20134: Desmond Molecular Dynamics System,"},{"key":"750_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-5-12","volume":"5","author":"D Ribble","year":"2005","unstructured":"Ribble D, Goldstein NB, Norris DA, Shellman YG (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 5:12. https:\/\/doi.org\/10.1186\/1472-6750-5-12","journal-title":"BMC Biotechnol"},{"key":"750_CR47","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/jhet.3880","volume":"57","author":"NA Harry","year":"2020","unstructured":"Harry NA, Radhika S, Neetha M, Anilkumar G (2020) A novel catalyst-free mechanochemical protocol for the synthesis of 2,3-dihydro-1H-perimidines. J Heterocycl Chem 57:2037\u20132043. https:\/\/doi.org\/10.1002\/jhet.3880","journal-title":"J Heterocycl Chem"},{"key":"750_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphi.2024.100641","author":"TR Paneru","year":"2024","unstructured":"Paneru TR, Chaudhary MK, Tandon P et al (2024) Theoretical study on molecular stability, reactivity, and drug potential of cirsilineol from DFT and molecular docking methods. Chem Phys Impact. https:\/\/doi.org\/10.1016\/j.chphi.2024.100641","journal-title":"Chem Phys Impact"},{"key":"750_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138772","volume":"1316","author":"M Premalatha","year":"2024","unstructured":"Premalatha M, Anitha K, Revathi B et al (2024) Delving into 5-Amino-3-(4-chlorophenyl)-1-isonicotinoyl-2,3-dihydro-1H-pyrazole-4-carbonitrile ligand: synthesis, spectroscopic (FT-IR, FT-Raman, NMR, UV- Vis), reactivity (ELF, LOL and Fukui), NCI, molecular docking and in silico ADMET studies by experimental and DFT methods. J Mol Struct 1316:138772. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138772","journal-title":"J Mol Struct"},{"key":"750_CR50","doi-asserted-by":"publisher","DOI":"10.1080\/00268976.2024.2332493","author":"P Jayavel","year":"2024","unstructured":"Jayavel P, Rajamanickam R, Amaladoss N et al (2024) Design, one-pot novel synthesis of substituted acridine derivatives: DFT, structural characterisation, ADME and anticancer DNA polymerase epsilon molecular docking studies. Mol Phys. https:\/\/doi.org\/10.1080\/00268976.2024.2332493","journal-title":"Mol Phys"},{"key":"750_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.137400","author":"Z Akbari","year":"2024","unstructured":"Akbari Z, Stagno C, Iraci N et al (2024) Biological evaluation, DFT, MEP, HOMO-LUMO analysis and ensemble docking studies of Zn(II) complexes of bidentate and tetradentate Schiff base ligands as antileukemia agents. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2023.137400","journal-title":"J Mol Struct"},{"key":"750_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138772","author":"M Premalatha","year":"2024","unstructured":"Premalatha M, Anitha K, Revathi B et al (2024) Delving into 5-Amino-3-(4-chlorophenyl)-1-isonicotinoyl-2,3-dihydro-1H-pyrazole-4-carbonitrile ligand: synthesis, spectroscopic (FT-IR, FT-Raman, NMR, UV- Vis), reactivity (ELF, LOL and Fukui), NCI, molecular docking and in silico ADMET studies by experimental and DFT methods. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138772","journal-title":"J Mol Struct"},{"key":"750_CR53","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2174\/1385272825666210316122319","volume":"25","author":"G Brahmachari","year":"2021","unstructured":"Brahmachari G, Nayek N, Mandal M et al (2021) Ultrasound-promoted organic synthesis - a recent update. Curr Org Chem 25:1539\u20131565. https:\/\/doi.org\/10.2174\/1385272825666210316122319","journal-title":"Curr Org Chem"},{"key":"750_CR54","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1071\/CH17080","volume":"70","author":"B Banerjee","year":"2017","unstructured":"Banerjee B (2017) Recent developments on ultrasound-assisted synthesis of bioactive N-heterocycles at ambient temperature. Aust J Chem 70:872. https:\/\/doi.org\/10.1071\/CH17080","journal-title":"Aust J Chem"},{"key":"750_CR55","doi-asserted-by":"publisher","first-page":"e202402907","DOI":"10.1002\/cbdv.202402907","volume":"22","author":"R Pal","year":"2025","unstructured":"Pal R, Matada GSP, Teli G (2025) Integrated computational and experimental insights into MEK1\/2 inhibitors: structural validation, docking, ADMET, molecular dynamics, and anticancer evaluation. Chem Biodivers 22:e202402907. https:\/\/doi.org\/10.1002\/cbdv.202402907","journal-title":"Chem Biodivers"},{"key":"750_CR56","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2174\/1568026618666180719164149","volume":"18","author":"A Gupta","year":"2018","unstructured":"Gupta A, Kumar V, Aparoy P (2018) Role of topological, electronic, geometrical, constitutional and quantum chemical based descriptors in QSAR: mPGES-1 as a case study. Curr Top Med Chem 18:1075\u20131090. https:\/\/doi.org\/10.2174\/1568026618666180719164149","journal-title":"Curr Top Med Chem"},{"key":"750_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.137561","author":"G Venkatesh","year":"2024","unstructured":"Venkatesh G, Sixto-L\u00f3pez Y, Vennila P et al (2024) Synthesis, solvent effects, chemical reactivity, molecular docking and molecular dynamic studies of triazole derivative. J Mol Struct. https:\/\/doi.org\/10.1016\/j.molstruc.2024.137561","journal-title":"J Mol Struct"},{"key":"750_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119264","volume":"10","author":"L Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez L (2015) Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS ONE 10:e0119264. https:\/\/doi.org\/10.1371\/journal.pone.0119264","journal-title":"PLoS ONE"},{"key":"750_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrd1097","volume":"2","author":"PAJ Janssen","year":"2003","unstructured":"Janssen PAJ (2003) A call to arms for drug discoverers. Nat Rev Drug Discov. 2:335\u2013335. https:\/\/doi.org\/10.1038\/nrd1097","journal-title":"Nat Rev Drug Discov."},{"key":"750_CR60","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/s41467-017-02258-w","volume":"8","author":"M Amaral","year":"2017","unstructured":"Amaral M, Kokh DB, Bomke J et al (2017) Protein conformational flexibility modulates kinetics and thermodynamics of drug binding. Nat Commun 8:2276. https:\/\/doi.org\/10.1038\/s41467-017-02258-w","journal-title":"Nat Commun"},{"key":"750_CR61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12964-025-02410-w","volume":"23","author":"S Bharadwaj","year":"2025","unstructured":"Bharadwaj S, Mierzwicka JM, Va\u0148kov\u00e1 L, Mal\u00fd P (2025) Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer. Cell Commun Signal 23:400. https:\/\/doi.org\/10.1186\/s12964-025-02410-w","journal-title":"Cell Commun Signal"},{"key":"750_CR62","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/jhet.3880","volume":"57","author":"NA Harry","year":"2020","unstructured":"Harry NA, Radhika S, Neetha M, Anilkumar G (2020) A novel catalyst-free mechanochemical protocol for the synthesis of 2,3-dihydro-1 H -perimidines. J Heterocycl Chem 57:2037\u20132043. https:\/\/doi.org\/10.1002\/jhet.3880","journal-title":"J Heterocycl Chem"},{"key":"750_CR63","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/jhet.4146","volume":"58","author":"NA Harry","year":"2021","unstructured":"Harry NA, Shilpa T, Ujwaldev SM, Anilkumar G (2021) A novel eco-friendly on-water protocol for the synthesis of 2,2-disubstituted 2,3-dihydro-1H-perimidines. J Heterocycl Chem 58:375\u2013381. https:\/\/doi.org\/10.1002\/jhet.4146","journal-title":"J Heterocycl Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00750-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00750-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:38:12Z","timestamp":1768019892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00750-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00750-w","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"44"}}